Clinical Trial Update: Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of methoxyamine with cisplatin and pemetrexed disodium in patients with advanced solid tumors or mesothelioma; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Malignant Solid Tumor
• Unresectable Solid Tumor

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• Methoxyamine (methoxyamine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Advanced Peritoneal Malignant Mesothelioma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-25